Intranodal Treatment With Ifnα-Dendritic Cells and Rituximab Induces Systemic Clinical Response and Endogenous Vaccination Against Follicular Lymphoma: Final Result of a Phase I Study

Hematological Oncology - United Kingdom
doi 10.1002/hon.126_2630

Related search